1 3 2
O U T P AT I E N T S U R G E R Y M A G A Z I N E O N L I N E | S E P T E M B E R 2 0 1 4
Imprimis Pharmaceuticals
Dropless Cataract Surgery
dropless.com
(858) 704-4040
Pricing:
Single-use,2 mL vial of Tri-Moxi: $20. Single-
use, 1 mL vial of Tri-Moxi+Vanc: $25.
FYI:
The antibiotic, steroidal and non-steroidal eye
drops that patients are prescribed after cataract sur-
gery are essential to optimal outcomes, but they're
dependent on patients sticking to their inconvenient
schedule, administering them 3 times a day for as
long as 3 weeks. Imprimis's proprietary compounded
formulations prevent the risk of post-op infection
and inflammation while simplifying patients' care by
doing away with post-op drops. A single intraopera-
tive injection of Tri-Moxi (triamcinolone acetonide
and moxifloxacin hydrochloride) or Tri-
Moxi+Vancomycin into the vitreous enables the
delivery of the meds over time and guarantees com-
pliance with the post-op care regimen and consistent
results. Prepared and tested under the supervision of
a licensed pharmacist, the formulations are cost-
effective alternatives to branded drops.
O P H T H A L M O L O G Y
